Replies to post #96381 on Creative Medical Technology Holdings Inc (CELZ)

[BigB111]

It makes me feel good that they are finally realizing they suck at their jobs and that we all think they are the worst executive management team on the planet! Great work Tim Warbington

Sent: Thursday, December 19, 2019 11:07 AM
To: [e-mail] <[e-mail]>; [e-mail] <[e-mail]>; Thomas Ichim <[e-mail]>
Subject: Re: EXECUTIVE TEAM

Just checking to see if today is the day that our incompetent executive team decides to communicate with shareholders? Is today the day or will it be like it always is.. ZERO TRANSPARENCY???

My Favorite arrogant PR is this one:
October 10, 2019
Shareholder Update: We Promised, We Delivered
Delivered a big pile of dog shit in the way of RS announcement a day later!!!

"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the
forefront as we close out the year," commented Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc. "I would also like to take a moment to thank our committed shareholders, as we recognize the stock price has not been reflective of the intrinsic value we have built in the company. Please rest assured we remain committed to increasing shareholder value, and believe your patience will be greatly rewarded in the near future."



On October 11, 2019, Creative Medical Technology Holdings, Inc. (the “Company”) completed the sale of 8% Original Issue Discount Senior Convertible Notes (“Notes”) to three institutional investors (the “Investors”) pursuant to a Securities Purchase Agreement between the Company and the Investors (the “Purchase Agreement”). The transaction was effected pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) promulgated thereunder.



Pursuant to the Purchase Agreement, for an aggregate purchase price of $275,000.00, the Investors purchased Notes in the aggregate principal amount of $297,000.00. Each Note matures on October 11, 2020, bears interest at a rate of 8% per annum, and is convertible into shares of the Company’s common stock at a conversion price equal to 60% of the lowest traded price of the Company’s common stock during the 15 trading days preceding the applicable conversion date.



The Purchase Agreement requires the Company to file a preliminary information statement with the Securities and Exchange Commission within 30 days following the closing to effect a reverse split of the Company’s Common Stock at a ratio of between one-for-25 and one-for-75 (the “Reverse Split”), and to cause the Reverse Split to become effective no later than December 30, 2019. In addition, the Notes are subject to covenants, events of defaults and other terms and conditions customary in transactions of this nature.


How was that suppose to add value to us as shareholders?

Where are you hiding Tim Warbington???